HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (7) Citing Articles via Google Scholar Google Scholar Articles by Notting, I. C. Articles by van der Pluijm, G. Search for Related Content PubMed PubMed Citation Articles by Notting, I. C. Articles by van der Pluijm, G.

Whole-Body Bioluminescent Imaging of Human Uveal Melanoma in a New Mouse Model of Local Tumor Growth and Metastasis

¹From the Departments of Ophthalmology and ²Endocrinology, Leiden University Medical Center, Leiden, The Netherlands.

PURPOSE. Human uveal melanoma develops in one of the most capillary-rich tissues of the body and has a pure hematogenous dissemination. Radiodiagnostic examinations, such as ultrasonic diagnostic resonance imaging and chest radiographs plus liver enzyme studies in blood, are methods used to detect liver and other distant metastases in patients. Nevertheless, the mortality rate is high, because of the frequent occurrence of metastases and the lack of systemic therapy. Therefore, the development of novel anticancer strategies is urgent, and more sensitive and less invasive methods of detecting and monitoring in vivo tumor growth and metastatic disease in cancer models are needed.

METHODS. A luciferase (Luc)-positive human uveal melanoma cell line (OCM-1 FRT/luc) was established. Tumor cells were inoculated into the anterior chamber of murine eyes for induction of orthotopic growth or into the left heart ventricle to mimic hematogenous micrometastatic spread. Development of metastases and tumor growth was monitored weekly by whole-body bioluminescent reporter imaging (BLI).

RESULTS. Injection of cancer cells into the anterior chamber of the eye of mice closely mimicked orthotopic tumor growth of uveal melanoma. Tumor progression could be quantitatively monitored 3 weeks after inoculation of 10⁵ OCM-1 FRT/luc cells. Of the mice injected, 83% exhibited a detectable tumor within 5 weeks. Intracardiac injection of tumor cells resulted in metastatic growth, especially in bone. Mice had bone (maxillofacial region and femora) and visceral (lung and mediastinum) metastases after 4 to 6 weeks. OCM-1 FRT/luc cells may also have a propensity to colonize the eye after intracardiac inoculation.

CONCLUSIONS. BLI enables continuous quantitative monitoring in the same animal of growth kinetics for each tumor and its metastases. This model will accelerate the understanding of the pathogenesis and treatment of uveal melanoma and metastasis.

This article has been cited by other articles:

				I. Notting, J. Buijs, R. Mintardjo, G. van der Horst, S. Vukicevic, C. Lowik, N. Schalij-Delfos, J. Keunen, and G. van der Pluijm Bone Morphogenetic Protein 7 Inhibits Tumor Growth of Human Uveal Melanoma In Vivo Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 4882 - 4889. [Abstract] [Full Text] [PDF]

				J. T. Buijs, N. V. Henriquez, P. G.M. van Overveld, G. van der Horst, I. Que, R. Schwaninger, C. Rentsch, P. ten Dijke, A.-M. Cleton-Jansen, K. Driouch, et al. Bone Morphogenetic Protein 7 in the Development and Treatment of Bone Metastases from Breast Cancer Cancer Res., September 15, 2007; 67(18): 8742 - 8751. [Abstract] [Full Text] [PDF]

				J.-C. A. Marshall, B. F. Fernandes, S. Di Cesare, S. C. Maloney, P. T. Logan, E. Antecka, and M. N. Burnier Jr The use of a cyclooxygenase-2 inhibitor (Nepafenac) in an ocular and metastatic animal model of uveal melanoma Carcinogenesis, September 1, 2007; 28(9): 2053 - 2058. [Abstract] [Full Text] [PDF]

				E. L. Kaijzel, G. van der Pluijm, and C. W.G.M. Lowik Whole-Body Optical Imaging in Animal Models to Assess Cancer Development and Progression Clin. Cancer Res., June 15, 2007; 13(12): 3490 - 3497. [Abstract] [Full Text] [PDF]